CF
Insider
Christine Fox
EVP, U.S. CommercialChristine Fox (EVP, U.S. Commercial) filed 5 Form 4 reports in the trailing twelve months (0 purchases, 5 sales), most often in Teva Pharmaceutical Industries Limited (TEVA). The largest single filing was $753K of TEVA (30,000 sh × $25.11, as filed), executed Nov 14 2025.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
5
0 buys · 5 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$2.7M
shares × price, as filed
Last traded
Apr 30
Filed May 4
Median ADV $196.1M across their filed names
Open performance→Volume by month
Buys $0
Sells $3.1M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
5 filings
Sector per market data · by filing · past 12 months
Most traded names
TEVARecent filings
TEVASALE
Teva Pharmaceutical Industries Limited
View filing →
$751K21,258 sh × $35.31
Exec Apr 30
Filed May 4 · 5:30 PM ET TEVASALE Teva Pharmaceutical Industries Limited View filing → $251K
7,924 sh × $31.67
Exec Mar 5
Filed Mar 9 · 5:30 PM ET TEVASALE Teva Pharmaceutical Industries Limited View filing → $295K
9,098 sh × $32.46
Exec Mar 4
Filed Mar 6 · 5:30 PM ET TEVASALE Teva Pharmaceutical Industries Limited View filing → $700K
28,229 sh × $24.78
Exec Nov 20 2025
Filed Nov 24 2025 · 5:30 PM ET TEVASALE Teva Pharmaceutical Industries Limited View filing → $753K
30,000 sh × $25.11
Exec Nov 14 2025
Filed Nov 18 2025 · 5:30 PM ET TEVASALE Teva Pharmaceutical Industries Limited View filing → $327K
19,388 sh × $16.87
Exec Nov 20 2024
Filed Nov 21 2024 · 5:30 PM ET